We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02943317
Recruitment Status : Terminated (The study was terminated upon completion of escalation phase, prior to opening expansion cohorts)
First Posted : October 24, 2016
Last Update Posted : April 30, 2019
Information provided by (Responsible Party):
Verastem, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 28, 2018
Actual Study Completion Date : December 28, 2018